Literature DB >> 28680466

Atrial fibrillation with a structurally normal heart in pregnancy: An international survey on current practice.

Annabelle Cumyn1, Nadine Sauvé1, Évelyne Rey2.   

Abstract

BACKGROUND: Little evidence exists for the optimal management of atrial fibrillation with a structurally normal heart in pregnancy.
METHODS: A survey was sent to members of two associations to obtain input on optimal management of atrial fibrillation in pregnancy. The survey presented four cases with respect to (1) baseline investigations; (2) rate versus rhythm control; (3) chemical versus electrical cardioversion; and (4) anticoagulation.
RESULTS: Sixty-one responders from 11 countries participated. High agreement was noted for baseline investigations. A quarter (25%) of participants chose elective cardioversion even with a reversible precipitant. Electrical cardioversion was preferred over chemical (p < 0.05). Anticoagulation strategies were heterogeneous except in the presence of a left atrial appendage thrombus. DISCUSSION: This study revealed that there was little consensus in current practice in pregnancy beyond basic investigations. An adaptation of established guidelines to the pregnant population would require a meeting of Cardiologists with input from colleagues in Obstetric Medicine.

Entities:  

Keywords:  High-risk pregnancy; cardiac; drugs (medication)

Year:  2017        PMID: 28680466      PMCID: PMC5480646          DOI: 10.1177/1753495X16685684

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  29 in total

1.  Lone atrial fibrillation during pregnancy.

Authors:  Ramesh M Gowda; Gopikrishna Punukollu; Ijaz A Khan; Sabrina L Wilbur; Victor S Navarro; Balendu C Vasavada; Terrence J Sacchi
Journal:  Int J Cardiol       Date:  2003-03       Impact factor: 4.164

2.  Expert consensus document on management of cardiovascular diseases during pregnancy.

Authors: 
Journal:  Eur Heart J       Date:  2003-04       Impact factor: 29.983

Review 3.  Treatment of cardiac arrhythmias during pregnancy: safety considerations.

Authors:  J A Joglar; R L Page
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 4.  Gender differences in arrhythmias.

Authors:  Deborah Wolbrette; Gerald Naccarelli; Anne Curtis; Michael Lehmann; Alan Kadish
Journal:  Clin Cardiol       Date:  2002-02       Impact factor: 2.882

5.  Atrial Fibrillation in a Structurally Normal Heart during Pregnancy: A Review of Cases From a Registry and From the Literature.

Authors:  Nadine Sauvé; Évelyne Rey; Annabelle Cumyn
Journal:  J Obstet Gynaecol Can       Date:  2016-12-10

Review 6.  Anticoagulation in pregnancy.

Authors:  Sorel Goland; Uri Elkayam
Journal:  Cardiol Clin       Date:  2012-08       Impact factor: 2.213

7.  Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Authors:  John A Cairns; Stuart Connolly; Sean McMurtry; Michael Stephenson; Mario Talajic
Journal:  Can J Cardiol       Date:  2011 Jan-Feb       Impact factor: 5.223

Review 8.  Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations.

Authors:  Ramesh M Gowda; Ijaz A Khan; Nirav J Mehta; Balendu C Vasavada; Terrence J Sacchi
Journal:  Int J Cardiol       Date:  2003-04       Impact factor: 4.164

Review 9.  Arrhythmias in the pregnant patient: current concepts in evaluation and management.

Authors:  Jordana Kron; Jamie B Conti
Journal:  J Interv Card Electrophysiol       Date:  2007-08-09       Impact factor: 1.900

10.  Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service.

Authors:  Jian-Ming Li; Carol Nguyen; Jose A Joglar; Mohamed H Hamdan; Richard L Page
Journal:  Clin Cardiol       Date:  2008-11       Impact factor: 2.882

View more
  1 in total

Review 1.  Women and atrial fibrillation.

Authors:  Annabelle Santos Volgman; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Gerald V Naccarelli; Carl J Pepine; Odayme Quesada; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-29       Impact factor: 2.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.